
Aims Scope
Aims and Scope:
Advances in Endocrinology & Metabolism (AIEM) stands as a distinguished international journal, committed to the dissemination of high-quality, original research and review papers in the realm of endocrinology and metabolism. With a rigorous peer-review process, AIEM ensures the publication of cutting-edge findings and advancements that shape our understanding of this multifaceted field.
The scope of AIEM encompasses all aspects of endocrinology and metabolism, addressing a wide range of topics to provide a comprehensive overview. From diabetes and obesity to thyroid disorders, pituitary disorders, reproductive endocrinology, and metabolic syndrome, the journal covers the diverse landscape of conditions and diseases that fall within the purview of endocrinology and metabolism.
Original research articles serve as the cornerstone of AIEM, highlighting the latest discoveries and breakthroughs in the field. These research contributions delve into the intricacies of hormonal regulation, metabolic pathways, and physiological processes, shedding light on the underlying mechanisms that govern endocrine and metabolic function. Through meticulous experimentation and data analysis, researchers contribute to the expanding knowledge base of endocrinology and metabolism, paving the way for improved diagnosis, treatment, and patient care.
AIEM also welcomes comprehensive review papers that critically evaluate existing literature and provide an in-depth synthesis of current knowledge and advancements. These reviews not only facilitate a deeper understanding of specific topics within endocrinology and metabolism but also assist researchers, clinicians, and healthcare professionals in navigating the rapidly evolving landscape of the field. By summarizing and analyzing the collective body of research, review papers help identify research gaps, propose future directions, and contribute to evidence-based practices in the field.
The primary objective of AIEM is to provide a platform for researchers, endocrinologists, and other healthcare professionals to disseminate their findings and foster scientific discourse. By facilitating knowledge sharing and collaboration, the journal catalyzes advancements in the field of endocrinology and metabolism. The interdisciplinary nature of endocrine and metabolic research necessitates the collaboration between basic scientists, clinical researchers, and healthcare practitioners. AIEM acts as a bridge, fostering connections and promoting the exchange of ideas among these diverse stakeholders.
Furthermore, AIEM plays a vital role in promoting evidence-based practices in endocrinology and metabolism. By publishing original research that investigates novel therapeutic interventions, diagnostic techniques, and preventive strategies, the journal contributes to the development of effective clinical approaches. The insights gained from these studies have the potential to improve patient outcomes, enhance quality of life, and address the global burden of endocrine and metabolic disorders.
In summary, Advances in Endocrinology & Metabolism (AIEM) is an esteemed international journal that advances the frontiers of endocrinology and metabolism through the publication of high-quality research and review papers. By providing a platform for the exchange of knowledge and ideas, AIEM fosters collaboration, drives innovation, and propels the field forward. Through the collective efforts of researchers, endocrinologists, and healthcare professionals, AIEM strives to improve our understanding of endocrine and metabolic disorders, ultimately leading to better healthcare practices and improved patient outcomes.
Classification:
- Hormones
- Histogenesis
- Organogenesis
- Metabolism
- Pediatric Endocrinology
- Neuroendocrinology
- Reproductive Endocrinology
- Comparative Endocrinology
- Adrenal Disorders
- Glucose Homeostasis
- Thyroid Disorders
- Calcium Homeostasis Disorders
- Pituitary Gland Disorders
- Sex Hormone Disorders
- Endocrine Emergencies
- Endocrine Tumors
- Diabetes-Endocrinology
- Ketoacidosis
- Beta Cell Loss
- Autoimmune Attack
- Hyperglycemia
- Obesity Risks
- Anti-obesity Drugs
- Gastric Balloonm
- Atypical Antipsychotic
- Mineralocorticoid Deficiency
- Adrenal Hormone Excess
- Thyroid Hormone Resistance
- Deformans (Paget’s Disease of Bone)
- Rickets and Osteomalacia
- Posterior Pituitary-Anterior Pituitary
- Hypopituitarism (or Panhypopituitarism)
- Prolactinoma (or Hyperprolactinemia)
- Acromegaly
- Gigantism Hermaphroditism
- Androgen Insensitivity Syndromes
- Hypogonadism (Gonadotropin Deficiency)
- Inherited (Genetic and Chromosomal) Disorders
- Kallmann Syndrome
- Klinefelter Syndrome
- Turner Syndrome
- Acquired Disorders
- Ovarian Failure (Also Known as Premature Menopause)
- Testicular Failure
- Disorders of Puberty
- Delayed Puberty
- Precocious Puberty
- Menstrual Function or Fertility Disorders
- Amenorrhea
- Polycystic Ovary Syndrome